BeStock  
Stocks › Medical Devices › PODD

Insulet PODD

US equityMarket cap rank #1477Medical Devices
$133.17 −$4.06 (-2.96%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $133.10 -0.05%
Open$134.97
Prev close$137.23
Day range$132.38 – $140.47
Volume1.80M
Market cap$9.24B
P/E (TTM)21.8
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$842.00M+19.2% YoY
Operating profit$189.80M+61.3% YoY
Net profit$141.10M+61.1% YoY
Diluted EPS$2.03+63.7% YoY
Free cash flow$61.60M-34.9% YoY
Operating cash flow$123.50M

Revenue, last 8 quarters

$597.5MDec '24$569.0MMar '25$649.1MJun '25$706.3MSep '25$783.8MDec '25$761.7MMar '26$801.7MJun '26$842.0MSep '26

Net profit, last 8 quarters

$100.7MDec '24$35.4MMar '25$22.5MJun '25$87.6MSep '25$101.6MDec '25$91.1MMar '26$95.0MJun '26$141.1MSep '26

Diluted EPS by quarter

1.39Dec '240.50Mar '250.32Jun '251.24Sep '251.44Dec '251.30Mar '261.37Jun '262.03Sep '26

Free cash flow by quarter

$91.5MDec '24$48.1MMar '25$173.3MJun '25$94.6MSep '25$33.9MDec '25$86.0MMar '26$51.1MJun '26$61.6MSep '26

Annual revenue

$904.4MFY20$1.1BFY21$1.3BFY22$1.7BFY23$2.1BFY24$2.7BFY25

Profitability & balance sheet

Gross margin71.9%
Operating margin18.4%
Net margin13.4%
Return on equity28.9%
Return on assets13.3%
Return on invested capital18.7%
Current ratio2.51
Liabilities / assets53.8%
Cash & investments$584.40M
Total debt$962.10M
Net cash (debt)-$377.70M
Free cash flow / sales7.3%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Omnipod products$836.60M 99.3%
  • Drug Delivery$5.50M 0.7%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $842.00M $801.70M $761.70M $2.71B $783.80M
Total Operating Revenue $842.00M $801.70M $761.70M $2.71B $783.80M
Cost of Revenue $209.90M $239.10M $232.70M $768.20M $215.20M
Gross Profit $632.10M $562.60M $529.10M $1.94B $568.60M
Operating Expense $442.30M $432.90M $406.90M $1.47B $422.30M
Selling and Admin Expenses $350.70M $344.80M $317.20M $1.17B $331.40M
Research & Development $91.60M $88.10M $89.70M $301.10M $90.90M
Operating Profit $189.80M $129.70M $122.20M $473.80M $146.30M
Net Non-Operating Interest Income (Expense) -$12.10M -$9.90M -$9.80M -$24.70M -$9.20M
Non-Operating Interest Income $4.10M $3.60M $4.90M $34.70M $5.70M
Non-Operating Interest Expense $16.20M $13.50M $14.70M $59.40M $14.90M
Other Income (Expense) -$500,000.00 -$1.10M $700,000.00 -$109.60M $3.10M
Special Income (Charges) -$300,000.00 $0.00 $0.00 -$123.90M $0.00
-Less:Other Special Charges $300,000.00 – – $123.90M $0.00
Other Non-Operating Income (Expenses) -$200,000.00 -$1.10M $700,000.00 $1.80M -$9.40M
Pretax Profit $177.20M $118.70M $113.00M $339.50M $140.20M
Tax $36.10M $23.70M $21.90M $92.40M $38.50M
Net Profit $141.10M $95.00M $91.10M $247.10M $101.60M
Profit from Continuing Operations $141.10M $95.00M $91.10M $247.10M $101.60M
Net Income to Parent Company $141.10M $95.00M $91.10M $247.10M $101.60M
Net Income to Common Stockholders $141.10M $95.00M $91.10M $247.10M $101.60M
Basic EPS $2.03 $1.37 $1.30 $3.51 $1.44
Diluted EPS $2.03 $1.37 $1.30 $3.48 $1.44
Gain on Sale of Security – – – $12.50M –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $3.42B $3.17B $2.99B $3.19B $3.19B
Total Current Assets $2.04B $1.85B $1.71B $1.91B $1.91B
Cash and Cash Equivalents & Short-Term Investments $584.40M $534.90M $480.40M $716.10M $716.10M
-Cash and Cash Equivalents $584.40M $534.90M $480.40M $716.10M $716.10M
Receivables $689.00M $588.70M $544.60M $517.00M $517.00M
-Accounts Receivable $679.70M $580.40M $542.10M $511.30M $511.30M
-Other Receivables $9.30M $8.30M $2.50M $5.70M $5.70M
Prepaid Assets $56.40M – – – –
Inventory $552.10M $484.80M $462.50M $452.60M $452.60M
Other Current Assets $159.60M $240.70M $222.00M $228.30M $228.30M
Total Non-Current Assets $1.37B $1.32B $1.28B $1.28B $1.28B
Net PPE $918.60M $858.60M $830.40M $819.40M $819.40M
Goodwill and Other Intangible Assets $166.40M $166.60M $166.90M $168.70M $168.70M
-Goodwill $51.60M $51.60M $51.60M $51.60M $51.60M
-Other Intangible Assets $114.80M $115.00M $115.30M $117.10M $117.10M
Other Non-Current Assets $288.60M $290.80M $280.60M $205.80M $205.80M
Total Liabilities $1.84B $1.74B $1.68B $1.68B $1.68B
Total Current Liabilities $814.40M $744.20M $687.50M $680.10M $680.10M
Payables $162.20M $123.30M $149.80M $75.00M $75.00M
-Accounts Payable $162.20M $123.30M $149.80M $75.00M $75.00M
Current Accrued Expenses $337.70M $311.10M $268.90M $263.70M $263.70M
Short-Term Debt and Capital Lease Obligation $19.10M $18.90M $18.60M $18.40M $18.40M
-Current Debt $19.10M $18.90M $18.60M $18.40M $18.40M
Other Current Liabilities $137.50M $137.10M $135.20M $113.80M $113.80M
Total Non-Current Liabilities $1.02B $998.70M $997.10M $995.00M $995.00M
Long Term Debt and Capital Lease Obligation $943.00M $929.50M $929.50M $930.80M $930.80M
-Long Term Debt $943.00M $929.50M $929.50M $930.80M $930.80M
Other Non-Current Liabilities $78.60M $69.20M $67.60M $64.20M $64.20M
Total Equity $1.58B $1.42B $1.30B $1.52B $1.52B
Stockholders' Equity $1.58B $1.42B $1.30B $1.52B $1.52B
Capital Stock $100,000.00 $100,000.00 $100,000.00 $100,000.00 $100,000.00
-Common Stock $100,000.00 $100,000.00 $100,000.00 $100,000.00 $100,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.33B $1.31B $1.28B $1.27B $1.27B
Retained Earnings $614.50M $473.50M $378.50M $287.40M $287.40M
Less: Treasury Stock -$363.30M -$363.50M -$363.30M -$60.40M -$60.40M
Gains/Losses Not Affecting Retained Earnings -$2.30M $1.90M $5.60M $12.50M $12.50M
Other Equity Interests $1.10M $1.20M $900,000.00 $800,000.00 $800,000.00
-Gross PPE – – – $1.25B $1.25B
-Accumulated Depreciation – – – -$432.80M -$432.80M
Non-Current Deferred Assets – – – $82.40M $82.40M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $123.50M $88.40M $113.80M $569.30M $183.30M
Net cash flow from continuing operations $123.40M $88.50M $113.80M $569.30M $183.30M
Net Income from Continuing Operations $141.00M $95.00M $91.10M $247.10M $101.60M
Depreciation & Depletion & Amortization $28.20M $26.70M $26.20M $90.40M $24.40M
Deferred Tax $13.30M $8.20M $7.00M $62.20M $19.50M
Other Non-Cash Items $1.90M $500,000.00 $300,000.00 $13.20M $2.80M
Change in Working Capital -$82.90M -$62.00M -$32.40M -$23.10M $14.50M
-Change in Receivables -$102.70M -$46.30M -$30.60M -$140.20M -$54.10M
-Change in Inventory -$68.10M -$23.40M -$11.50M -$10.60M -$5.90M
-Change in Prepaid Assets $21.30M -$35.70M $7.60M -$81.70M -$26.20M
-Change in Payables and Accrued Expense $66.60M $43.40M $2.10M $209.40M $100.70M
Net cash flow from investing -$66.90M -$37.40M -$27.70M -$222.70M -$152.80M
Net Cash Flow from Continuing Investing Activities -$66.90M -$37.30M -$27.80M -$222.60M -$152.60M
Capital Expenditure -$57.10M -$32.50M -$24.30M -$191.60M -$135.10M
Net Intangibles Purchase and Sale -$4.80M -$4.80M -$3.50M -$27.80M -$14.30M
Financing Cash Flow -$6.00M $4.00M -$319.90M -$595.30M -$72.50M
Net Cash Flow from Continuing Financing Activities -$5.90M $3.90M -$319.80M -$595.10M -$72.50M
Net Issuance Payments Of Debt -$5.40M -$4.60M -$4.50M -$708.10M -$81.30M
Net Common Stock Issuance $0.00 $0.00 -$300.00M -$59.60M $0.00
Proceeds from Stock Option Exercised $200,000.00 $9.00M $400,000.00 $198.50M $9.60M
Net Other Financing Charges -$800,000.00 -$400,000.00 -$15.80M -$26.10M -$800,000.00
Ending Cash Balance $584.40M $534.90M $480.40M $716.10M $716.10M
Net Change in Cash $50.60M $55.00M -$233.80M -$248.80M -$42.00M
Beginning Cash Balance $534.90M $480.40M $716.10M $953.40M $757.40M
Effect of Exchange Rate Changes -$1.10M -$500,000.00 -$1.90M $11.50M $700,000.00
Free Cash Flow $61.60M $51.10M $86.00M $349.90M $33.90M
Net Other Investing Changes – – $100,000.00 -$3.30M -$3.40M
Gain/Loss from Continuing Operations – – – $111.40M $0.00
Net Investment Purchase and Sale – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on PODD.

Sign in to join the discussion.

Scroll to Top